Top prevention news from 2022: Statins vs. supplements; avocado to lower CV risk; and more

Healio and Cardiology Today have compiled a list of the most-read news of 2022 in CHD and prevention.

Readers were most interested in the association between statin-induced LDL lowering and CV outcomes; how the timing of exercise may improve heart health; 2-decade patterns in U.S. cardiometabolic health; and more.

Meta-analysis questions strength of ties between statin-induced LDL lowering, CV outcomes

The link between statin-induced LDL lowering and reduction of CV outcomes may not be as robust as assumed, researchers who conducted a meta-analysis published in JAMA Internal Medicine concluded. Read more

Sperling: Messaging around aspirin could be better

The question of who should take aspirin is a complicated one and public messaging on it is sometimes confusing, a speaker said at the Heart in Diabetes CME conference. Read more

Exercising in the morning could reduce CVD risk

The timing of physical activity could affect the risk for CVD, according to study findings published in the European Journal of Preventive Cardiology. Read more

Meta-analysis: Testosterone treatment not linked to short-, medium-term CV events in men

In men with hypogonadism, there was no evidence that testosterone treatments cause short-term or medium-term CV risks, according to a meta-analysis published in The Lancet Healthy Longevity. Read more

Statin therapy ‘vastly superior’ to common dietary supplements for cholesterol lowering

Daily rosuvastatin lowered LDL, total cholesterol and serum triglycerides significantly more than placebo and six common over-the-counter dietary supplements, with no supplement lowering LDL more than placebo. Read more

Two servings of avocado per week may lower risk for CVD, CHD

Two servings of avocado per week, compared with not eating any avocado, was associated with lower risk for CVD and CHD, but not stroke. Read more

Declines in US cardiometabolic health ‘striking’; disparities persist over 2 decades

The prevalence of optimal cardiometabolic health among U.S. adults declined in the past 2 decades, with disparity gaps widening based on age, sex, education and race. Read more

‘Weekend warrior’, regular physical activity patterns both reduce mortality risk

All-cause and CVD mortality were reduced in individuals regularly physically active as well as those only physically active on the weekend, according to a research letter in the European Journal of Preventive Cardiology. Read more

Consuming chili pepper linked to lower all-cause, CV, cancer-related mortality

The regular consumption of chili pepper was associated with significantly lower all-cause, CV and cancer-related mortality, according to findings published in the American Journal of Preventive Cardiology. Read more

Aspirin ‘benefit may outweigh harm’ in some elevated Lp(a) genotypes

Low-dose aspirin for primary prevention of CV events may benefit older adults with elevated lipoprotein(a)-associated genotypes, according to a new analysis of the ASPREE trial. Read more